An international leader in cancer genetics, Dr. Olopade seeks to identify those at risk for breast and ovarian cancer earlier in life, intervene aggressively, reduce risk, and thereby more effectively control cancer. She studies familial forms of cancers, molecular mechanisms of tumor progression in high-risk individuals as well as genetic and epigenetic factors contributing to disparities in cancer outcomes in diverse populations. Her current laboratory research is focused on using whole genome technologies and bioinformatics to develop innovative approaches to reduce global disparities in cancer outcomes. Dr. Olopade is an expert in cancer risk assessment and individualized treatment for the most aggressive forms of breast cancer, having developed novel management strategies based on an understanding of the altered genes in individual patients. She stresses comprehensive risk reducing strategies and prevention in high-risk populations, as well as earlier detection through advanced imaging technologies.